---
figid: PMC9416627__pharmaceutics-14-01590-g003
figtitle: 'Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets
  and Potent Drug Candidates'
organisms:
- NA
pmcid: PMC9416627
filename: pharmaceutics-14-01590-g003.jpg
figlink: /pmc/articles/PMC9416627/figure/pharmaceutics-14-01590-f003/
number: F3
caption: Inhibition of GPI biosynthesis pathway in Leishmania by different repurposed
  and/or potential drug candidates.
papertitle: 'Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets
  and Potent Drug Candidates.'
reftext: Surbhi Jain, et al. Pharmaceutics. 2022 Aug;14(8):1590.
year: '2022'
doi: 10.3390/pharmaceutics14081590
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: Leishmania | human pathogen | targeting metabolic pathways | repurposed
  drugs | new anti-leishmanials
automl_pathway: 0.8271841
figid_alias: PMC9416627__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC9416627__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9416627__pharmaceutics-14-01590-g003.html
  '@type': Dataset
  description: Inhibition of GPI biosynthesis pathway in Leishmania by different repurposed
    and/or potential drug candidates.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pgi
  - gp
  - pi
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - as
  - side
  - Sidpn
---
